Skip to content
Norton & Elaine Sarnoff Center for Jewish Genetics Logo
  • Home
  • About Us
    • Board Members
    • Staff
  • Genetic Disorders
    • Types of Genetic Disorders
    • Jewish Genetic Disorder FAQs
    • Rabbinical Insights
  • Hereditary Cancer
    • BRCA Mutations
    • Lynch Syndrome
    • Assess Your Risk
    • Cancer FAQs
    • Cancer Resources
  • Resources
    • Family Health History
    • Teach Jewish Genetics
    • For Medical Professionals
    • Personal Stories
    • Blog
    • Events
  • Donate
  • Get Screened

Phenylalanine hydroxylase deficiency

Phenylalanine hydroxylase deficiency (PHD) is a treatable metabolic disorder in which the body cannot properly break down the amino acid phenylalanine, a building block of protein.

Accumulation of phenylalanine can cause varying degrees of intellectual disability, developmental delay, seizures, and behavioral problems. Symptoms can arise shortly after birth.

PHD is caused by pathogenic (disease-causing) variants in the PAH gene and exhibits autosomal recessive inheritance. This means that both parents must be carriers to have a 25% chance to have a child with the condition. The risk of being a carrier is based on a person’s ancestry or ethnic background. Individuals of Ashkenazi Jewish descent have a 1 in 225 chance to be a carrier of PHD.

Carriers of this condition typically do not experience any symptoms.

Another name for this condition is phenylketonuria (PKU).

Share this
Tweet this
Email this

The Norton & Elaine Sarnoff Center for Jewish Genetics is a supporting foundation of the Jewish United Fund, and is supported in part by the Michael Reese Health Trust.

30 S Wells
Chicago, IL 60606
312-357-4718
jewishgenetics@juf.org

About
  • About Us
  • Genetic Disorders
  • Hereditary Cancer
  • Donate
Resources
  • Medical Professionals
  • Teach Jewish Genetics
  • Events

©2023 Norton & Elaine Sarnoff Center for Jewish Genetics

Page load link
Go to Top